Correlation Between Tel Aviv and Nextage Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tel Aviv and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tel Aviv and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tel Aviv 35 and Nextage Therapeutics, you can compare the effects of market volatilities on Tel Aviv and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tel Aviv with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tel Aviv and Nextage Therapeutics.
Diversification Opportunities for Tel Aviv and Nextage Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tel and Nextage is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Tel Aviv 35 and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Tel Aviv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tel Aviv 35 are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Tel Aviv i.e., Tel Aviv and Nextage Therapeutics go up and down completely randomly.
Pair Corralation between Tel Aviv and Nextage Therapeutics
Assuming the 90 days trading horizon Tel Aviv is expected to generate 6.91 times less return on investment than Nextage Therapeutics. But when comparing it to its historical volatility, Tel Aviv 35 is 8.63 times less risky than Nextage Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Nextage Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 4,420 in Nextage Therapeutics on August 26, 2024 and sell it today you would earn a total of 3,680 from holding Nextage Therapeutics or generate 83.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.67% |
| Values | Daily Returns |
Tel Aviv 35 vs. Nextage Therapeutics
Performance |
| Timeline |
Tel Aviv and Nextage Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Tel Aviv 35
Pair trading matchups for Tel Aviv
Nextage Therapeutics
Pair trading matchups for Nextage Therapeutics
Pair Trading with Tel Aviv and Nextage Therapeutics
The main advantage of trading using opposite Tel Aviv and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tel Aviv position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.| Tel Aviv vs. Feat Fund Investments | Tel Aviv vs. Libra Insurance | Tel Aviv vs. Blender Financial Technologies | Tel Aviv vs. Clal Insurance Enterprises |
| Nextage Therapeutics vs. Netz Hotels | Nextage Therapeutics vs. Migdal Insurance | Nextage Therapeutics vs. Harel Insurance Investments | Nextage Therapeutics vs. Menora Miv Hld |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |